{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:34:48Z","timestamp":1780338888096,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T00:00:00Z","timestamp":1467072000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s11255-016-1324-x","type":"journal-article","created":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T13:20:07Z","timestamp":1467120007000},"page":"1863-1871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease"],"prefix":"10.1007","volume":"48","author":[{"given":"Wen-Ling","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Bing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,28]]},"reference":[{"key":"1324_CR1","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","volume":"350","author":"CF Thomas Jr","year":"2004","unstructured":"Thomas CF Jr, Limper AH (2004) Pneumocystis pneumonia. N Engl J Med 350:2487\u20132498","journal-title":"N Engl J Med"},{"key":"1324_CR2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2334-11-76","volume":"11","author":"Y Matsumura","year":"2011","unstructured":"Matsumura Y, Shindo Y, Iinuma Y, Yamamoto M, Shirano M et al (2011) Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes. BMC Infect Dis 11:76\u201384","journal-title":"BMC Infect Dis"},{"issue":"8","key":"1324_CR3","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1097\/MIB.0b013e318281f562","volume":"19","author":"PN Okafor","year":"2013","unstructured":"Okafor PN, Nunes DP, Farraye FA (2013) Pneumocystis jiroveci pneumonia in inflammatory bowel disease: when should prophylaxis be considered? Inflam Bowel Dis 19(8):1764\u20131771","journal-title":"Inflam Bowel Dis"},{"issue":"5","key":"1324_CR4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1399-3062.2012.00740.x","volume":"14","author":"EH Wang","year":"2012","unstructured":"Wang EH, Partovi N, Levy RD et al (2012) Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past. Transpl Infect Dis 14(5):519\u2013525","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"1324_CR5","doi-asserted-by":"crossref","first-page":"e101943","DOI":"10.1371\/journal.pone.0101943","volume":"9","author":"F Guo","year":"2014","unstructured":"Guo F, Chen Y, Yang SL et al (2014) Pneumocystis pneumonia in HIV-infected and immunocompromised non-HIV infected patients: a retrospective study of two centers in China. PLoS ONE 9(7):e101943","journal-title":"PLoS ONE"},{"issue":"12","key":"1324_CR6","doi-asserted-by":"crossref","first-page":"1242.e11","DOI":"10.1016\/j.amjmed.2014.07.010","volume":"127","author":"P Fillatre","year":"2014","unstructured":"Fillatre P, Decaux O, Jouneau S et al (2014) Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients. Am J Med 127(12):1242.e11\u20131242.e17","journal-title":"Am J Med"},{"issue":"3","key":"1324_CR7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/00365548.2013.865142","volume":"46","author":"F Roblot","year":"2014","unstructured":"Roblot F, Le Moal G, Kauffmann-Lacroix C et al (2014) Pneumocystis jirovecii pneumonia in HIV-negative patients: a prospective study with focus on immunosuppressive drugs and markers of immune impairment. Scand J Infect Dis 46(3):210\u2013214","journal-title":"Scand J Infect Dis"},{"issue":"9818","key":"1324_CR8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang F, Wang L et al (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379(9818):815\u2013822","journal-title":"Lancet"},{"issue":"9","key":"1324_CR9","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1093\/ndt\/gfn161","volume":"23","author":"J Lv","year":"2008","unstructured":"Lv J, Zhang H, Cui Z et al (2008) Delayed severe pneumonia in mycophenolate mofetil-treated patients with IgA nephropathy. Nephrol Dial Transpl 23(9):2868\u20132872","journal-title":"Nephrol Dial Transpl"},{"key":"1324_CR10","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.2169\/internalmedicine.51.6774","volume":"51","author":"CY Yang","year":"2012","unstructured":"Yang CY, Yang AH, Yang WC, Lin CC (2012) Risk factors for Pneumocystis jiroveci pneumonia in glomerulonephritis patients receiving immunosuppressants. Intern Med 51:2869\u20132875","journal-title":"Intern Med"},{"issue":"6","key":"1324_CR11","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10156-012-0453-0","volume":"18","author":"S Tasaka","year":"2012","unstructured":"Tasaka S, Tokuda H (2012) Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies. J Infect Chemother 18(6):793\u2013806","journal-title":"J Infect Chemother"},{"key":"1324_CR12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000313717","volume":"164","author":"DN Cruz","year":"2010","unstructured":"Cruz DN, Bagshaw SM, Ronco C, Ricci Z (2010) Acute kidney injury: classification and staging. Contrib Nephrol 164:24\u201332","journal-title":"Contrib Nephrol"},{"issue":"6","key":"1324_CR13","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/MNH.0b013e32834ba210","volume":"20","author":"M Madero","year":"2011","unstructured":"Madero M, Sarnak MJ (2011) Creatinine-based formulae for estimating glomerular filtration rate: is it time to change to chronic kidney disease epidemiology collaboration equation? Curr Opin Nephrol Hypertens 20(6):622\u2013630","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1324_CR14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1440-1843.2009.01660.x","volume":"15","author":"T Enomoto","year":"2010","unstructured":"Enomoto T, Azuma A, Kohno A et al (2010) Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection. Respirology 15:126\u2013131","journal-title":"Respirology"},{"issue":"3","key":"1324_CR15","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1378\/chest.118.3.704","volume":"118","author":"NG Mansharamani","year":"2000","unstructured":"Mansharamani NG, Garland R, Delaney D, Koziel H (2000) Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 118(3):704\u2013711","journal-title":"Chest"},{"issue":"12","key":"1324_CR16","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/rheumatology\/kes244","volume":"51","author":"S Mori","year":"2012","unstructured":"Mori S, Sugimoto M (2012) Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis. Rheumatology (Oxford) 51(12):2120\u20132130","journal-title":"Rheumatology (Oxford)"},{"key":"1324_CR17","doi-asserted-by":"publisher","unstructured":"Plakke MJ, Jalota L, Lloyd BJ (2013) Pneumocystis pneumonia in a non-HIV patient on chronic corticosteroid therapy: a question of prophylaxis. BMJ Case Rep. doi: 10.1136\/bcr-2012-007912","DOI":"10.1136\/bcr-2012-007912"},{"key":"1324_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","volume":"71","author":"SH Yale","year":"1996","unstructured":"Yale SH, Limper AH (1996) Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illnesses and prior corticosteroid therapy. Mayo Clin Proc 71:5\u201313","journal-title":"Mayo Clin Proc"},{"key":"1324_CR19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/CPM.0b013e31823e2401","volume":"19","author":"LippmannML GripaldoR","year":"2012","unstructured":"GripaldoR LippmannML (2012) Pneumocystis pneumonia in HIV-negative patients: a review of the literature. Clin Pulm Med 19:5\u201313","journal-title":"Clin Pulm Med"},{"key":"1324_CR20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/QCO.0b013e32834cac17","volume":"24","author":"AB Reid","year":"2011","unstructured":"Reid AB, Chen SC, Worth LJ (2011) Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools. Curr Opin Infect Dis 24:534\u2013544","journal-title":"Curr Opin Infect Dis"},{"key":"1324_CR21","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1093\/ndt\/14.12.2807","volume":"14","author":"M Girndt","year":"1999","unstructured":"Girndt M, Sester U, Sester M, Kaul H, Kohler H (1999) Impaired cellular immunity in patients with end-stage renal failure. Nephrol Dial Transpl 14:2807\u20132810","journal-title":"Nephrol Dial Transpl"},{"key":"1324_CR22","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1046\/j.1523-1755.2001.59780206.x","volume":"78","author":"M Girndt","year":"2001","unstructured":"Girndt M, Sester M, Sester U, Kaul H, Kohler H (2001) Molecular aspects of T- and B-cell function in uremia. Kidney Int 78:S206\u2013S211","journal-title":"Kidney Int"},{"issue":"1","key":"1324_CR23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.jrn.2011.10.020","volume":"22","author":"ND Vaziri","year":"2012","unstructured":"Vaziri ND, Pahl MV, Crum A, Norris K (2012) Effect of uremia on structure and function of immune system. J Ren Nutr 22(1):149\u2013156","journal-title":"J Ren Nutr"},{"key":"1324_CR24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.ki.5001550","volume":"70","author":"J Yoon","year":"2006","unstructured":"Yoon J, Gollapudi S, Pahl M, Vaziri N (2006) Na\u00efve and central memory T-cell lymphopenia in end-stage renal disease. Kidney Int 70:371\u2013376","journal-title":"Kidney Int"},{"key":"1324_CR25","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1046\/j.1523-1755.2001.59780195.x","volume":"78","author":"S Massry","year":"2001","unstructured":"Massry S, Smogorzewski M (2001) Dysfunction of polymorphonuclear leukocytes in uremia: role of parathyroid hormone. Kidney Int 78:S195\u2013S196","journal-title":"Kidney Int"},{"key":"1324_CR26","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1046\/j.1523-1755.2001.59780186.x","volume":"78","author":"M Smogorzewski","year":"2001","unstructured":"Smogorzewski M, Massry SG (2001) Defects in B-cell function and metabolism in uremia: role of parathyroid hormone. Kidney Int 78:S186\u2013S189","journal-title":"Kidney Int"},{"key":"1324_CR27","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/ndt\/gfq689","volume":"26","author":"F Eitner","year":"2011","unstructured":"Eitner F, Hauser IA, Rettkowski O et al (2011) Risk factors for Pneumocystis jiroveci pneumonia (PCP) in renal transplant recipients. Nephrol Dial Transpl 26:2013\u20132017","journal-title":"Nephrol Dial Transpl"},{"issue":"7","key":"1324_CR28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10096-002-0758-5","volume":"21","author":"F Roblot","year":"2002","unstructured":"Roblot F, Godet C, Le Moal G et al (2002) Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis 21(7):523\u2013531","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1324_CR29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1378\/chest.128.2.573","volume":"128","author":"E Festic","year":"2005","unstructured":"Festic E, Gajic O, Limper AH, Aksamit TR (2005) Acute respiratory failure due to Pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features. Chest 128:573\u2013579","journal-title":"Chest"},{"issue":"2","key":"1324_CR30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10096-012-1730-7","volume":"32","author":"P Fillatre","year":"2013","unstructured":"Fillatre P, Chevrier S, Revest M et al (2013) Human herpes virus co-infection is associated with mortality in HIV-negative patients with Pneumocystis jirovecii pneumonia. Eur J Clin Microbiol Infect Dis 32(2):189\u2013194","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"1324_CR31","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/jac\/dks030","volume":"67","author":"TN Fraser","year":"2012","unstructured":"Fraser TN, Avellaneda AA, Graviss EA, Musher DM (2012) Acute kidney injury associated with trimethoprim\/sulfamethoxazole. J Antimicrob Chemother 67(5):1271\u20131277","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"1324_CR32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1365-2710.1998.00152.x","volume":"23","author":"H Klinker","year":"1998","unstructured":"Klinker H, Langmann P, Zilly M, Richter E (1998) Drug monitoring during the treatment of AIDS-associated Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole. J Clin Pharm Ther 23(2):149\u2013154","journal-title":"J Clin Pharm Ther"},{"issue":"9","key":"1324_CR33","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1128\/AAC.35.9.1884","volume":"35","author":"RC Stevens","year":"1991","unstructured":"Stevens RC, Laizure SC, Williams CL, Stein DS (1991) Pharmacokinetics and adverse effects of 20-mg\/kg\/day trimethoprim and 100-mg\/kg\/day sulfamethoxazole in healthy adult subjects. Antimicrob Agents Chemother 35(9):1884\u20131890","journal-title":"Antimicrob Agents Chemother"},{"key":"1324_CR34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.1980.03310040042025","volume":"244","author":"EJ Smith","year":"1980","unstructured":"Smith EJ, Light JA, Filo RS, Yum MN (1980) Interstitial nephritis caused by trimethoprim-sulfamethoxazole in renal transplant recipients. JAMA 244:360\u2013361","journal-title":"JAMA"},{"key":"1324_CR35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000185711","volume":"53","author":"T Rudra","year":"1989","unstructured":"Rudra T, Webb DB, Evans AG (1989) Acute tubular necrosis following co-trimoxazole therapy. Nephron 53:85\u201386","journal-title":"Nephron"},{"issue":"4","key":"1324_CR36","first-page":"1","volume":"58","author":"JE Kaplan","year":"2009","unstructured":"Kaplan JE, Benson C, Holmes KK et al (2009) Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recommend Rep 58(4):1\u2013207","journal-title":"MMWR Recommend Rep"},{"key":"1324_CR37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4065\/71.1.102","volume":"71","author":"KA Sepkowitz","year":"1996","unstructured":"Sepkowitz KA (1996) Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: who should receive prophylaxis? Mayo Clin Proc 71:102\u2013103","journal-title":"Mayo Clin Proc"},{"key":"1324_CR38","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1378\/chest.118.3.712","volume":"118","author":"NG Mansharamani","year":"2000","unstructured":"Mansharamani NG, Balachandran D, Vernovsky I, Garland R, Koziel H (2000) Peripheral Blood CD4 1 T-Lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest 118:712\u2013720","journal-title":"Chest"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-016-1324-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-016-1324-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-016-1324-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T13:21:22Z","timestamp":1498310482000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-016-1324-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,28]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["1324"],"URL":"https:\/\/doi.org\/10.1007\/s11255-016-1324-x","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,28]]}}}